Pharmaunternehmen

The Pharmaceutical Companies theme covers firms engaged in discovering, developing, manufacturing, and commercializing medicines, spanning small molecules and biologics. Core tracks include innovative therapeutics (oncology, immunology, CNS), vaccines, generics and biosimilars, specialty pharma, and enabling services (CDMOs/CROs); key value drivers include pipeline productivity, patent cliffs, regulatory milestones, pricing and market access, and global commercialization.The sector's total market cap is 290.39 billion HKD, with a 24h change of +0.60%. Among 47 constituents, 22 are up (46.81%) and 20 are down (42.55%). The top gainer is MPCARDIOFLOW-B (02160), with a 24h increase of +14.28%.Modest sector advance with mixed breadth and leader concentration. Trade momentum names on dips; prioritize innovators with strong pipelines, solid cash flow, and clear regulatory catalysts for medium-term positioning.